Synpromics is the leader in gene control, improving human health by enabling safer, more effective cell and gene medicines through proprietary genomics, bioinformatics and intelligent data driven design. Synpromics enables unprecedented control of gene expression through its ability to custom design synthetic cell-type, or condition, specific promoters. We achieve this by using proprietary technology and cutting edge techniques including sophisticated bioinformatics and screening approaches.
Looking for a particular Synpromics Ltd employee's phone or email?
The Synpromics Ltd annual revenue was $19.4 million in 2026.
Andrei Lyne is the CFO of Synpromics Ltd.
3 people are employed at Synpromics Ltd.
The NAICS codes for Synpromics Ltd are [325, 3254, 32].
The SIC codes for Synpromics Ltd are [283, 28].